PEGS Summit Korea
PEGS Korea

2016년 주요 연사


Amer Alghabban, MSc Pharmacol., Vice President, GxP Quality Assurance, Compliance and Training, Research & Development, Karyopharm Therapeutics, Inc.

Patrick Baeuerle, Ph.D., Managing Director, MPM Capital

Inpyo Choi, Ph.D., Director, Immunotherapy Convergence Center, Korea Research Institute of Bioscience & Biotechnology

Daniel Christ, Ph.D., Associate Professor and Director, Centre for Targeted Therapy, Immunology Program, Garvan Institute of Medical Research

Dimiter Dimitrov, Ph.D., Senior Investigator, Cancer Inflammation Program, National Cancer Institute, NIH

Jonathan M. Gershoni, Ph.D., Professor, Cell Research and Immunology, Tel Aviv University

Rui Gong, Ph.D., Professor & Head, Antibody Engineering Group, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences

Philip Gotwals, Ph.D., Executive Director, Exploratory Immuno-Oncology, Novartis Institutes of Biomedical Research

Felix Hart, Scientist, Preclinical Pharmacology & ADCs, Glycotope GmbH

Peer Heine, Ph.D., Field Application Scientist, Research & Development, MaxCyte

Sean Hu, Ph.D., Founder, Dophen Biomed

Tomoyuki Igawa, Ph.D., Head of Biologics Discovery, Research Division, Chugai Pharmaceutical Co., Ltd.

Yong-Sung Kim, Ph.D., Professor, Molecular Science & Technology, Ajou University

Bong-Kook Ko, Ph.D., Deputy Director, Antibody Therapeutic Research Center, AbClon, Inc.

Sukmook Lee, Ph.D., Principal Investigator, Research Center, Scripps Korea Antibody Institute

Hyung-Kwon (Harry) Lim, Ph.D., Antibody Engineering, Mogam Biotechnology Institute

Ji-Young Min, Ph.D., Principal Investigator, Head, Respiratory Viruses Research Laboratory, Discovery Biology Department, Institute Pasteur Korea

Julia Neugebauer, Ph.D., Assistant Director, Discovery, Alliances & Technologies, Morphosys AG

Bruce Nianhe Han, Ph.D., CSO, NewBio Therapeutics

Johan Nilvebrant, Ph.D., Researcher, Protein Technology, Royal Institute of Technology

Keiya Ozawa, M.D., Ph.D., Director, IMSUT Hospital, Director, Center for Gene & Cell Therapy, Professor, Division of Genetic Therapeutics, University of Tokyo

Sofie Pattijn, CTO, ImmunXperts

Jonas Schaefer, Ph.D., Head, High-Throughput Binder Selection Facility, Department of Biochemistry, University of Zurich

Jieyi Wang, Ph.D., Senior Principal Scientist, Oncology Biologics, AbbVie

Young Woo Park, Ph.D., CEO, Y Biologics

Chengbin Wu, Ph.D., CEO, EpimAb Biotherapeutics

William R. Strohl, Ph.D., Vice President and Biologics Fellow, Janssen Research & Development, LLC

Weikang Tao, Ph.D., Vice President & CEO, R&D Center, Jiangsu Hengrui Medicine Co., Ltd.

Kye Sook Yi, Ph.D., Senior Manager and Team Leader, New Antibody Development, R&D, Celltrion

Tianlei Ying, Ph.D., Professor, Antibody Engineering and Drug Discovery Group, Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences,

Fudan University, China

Jin-San Yoo, Ph.D., CEO, President and Founder, PharmAbcine

Paul Youm, J.D., Legal Counsel, SillaJen, Inc.

Zhenping Zhu, M.D., Ph.D., Executive Vice President, Global Biologics R&D, Kadmon Corporation, LLC

Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English



기업 스폰서

 MaxCyte

기업 지원 스폰서


GeneScript

스폰서 조직


theAntibodySocietyLogo

Antibody Society Korea



Arrow Right Col미디어 파트너


 

트랙 1
Arrow Right Col 단백질 엔지니어링과 항체 엔지니어링


트랙 2
Arrow Right Col 암 면역치료




Catalog
국제컨퍼런스
Giievent
메일링 서비스